TITLE

FDA Actions

PUB. DATE
October 2009
SOURCE
Internal Medicine Alert;10/16/2009 Supplement, p2
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the actions made by the U.S. Food & Drug Administration (FDA) with regards to the administration and marketing of several drugs including tumor necrosis factor (TNF)-blockers, dipeptidyl peptidase-4 (DPP-4) and orlistat.
ACCESSION #
44960616

 

Related Articles

  • New influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu): unexpected serious reactions.  // CMAJ: Canadian Medical Association Journal;10/03/2000, Vol. 163 Issue 7, p879 

    Reports on the influenza drugs zanamivir and oseltamivir approved for sale in Canada. Adverse reactions to the drugs as monitored by the Canadian Adverse Drug Reaction Monitoring Programme (CADRMP); Issue of a Public Health Advisory from the United States Food and Drug Administration which...

  • product showcase.  // Pharmacy Today;Oct2010, Vol. 16 Issue 10, p20 

    The article offers several medicines which granted approval from the U.S. Food and Drug Administration (FDA). FDA has approved ranibizumab injection in treating macular edema following retinal vein occlusion. Reckitt Benckiser's buprenorphine/nalooxone sublingual film has gained approval for...

  • Prescription ads next on FDA list. Colford, S.W. // Advertising Age;8/26/91, Vol. 62 Issue 35, p32 

    Examines Food & Drug Administration (FDA) plans to tighten regulations on drug advertising and various promotional practices. Principal concerns of Commissioner David Kessler; Present regulations of consumer ads for prescription drugs.

  • Over-the-counter drugs. Sommi Jr., R.W. // Current Health 2;May92, Vol. 18 Issue 9, p21 

    Discusses the differences between prescription and nonprescription drugs (also called over-the-counter, or OTC, drugs). Role of the US Food and Drug Administration (FDA); OTC drugs for self-limiting illnesses such as the common cold; The FDA's concern about side effects, clear instructions and...

  • The FDA safeguarding. Kowalski, Kathiann M. // Current Health 2;Jan1996, Vol. 22 Issue 5, p20 

    Presents the work and duties of the Food and Drug Administration (FDA) in the United States. Origin of the agency; Rules followed on food standard inspection; Presence of food chemicals; Safety programs of FDA; Actions of the agency in the presence of problems; Nutrition labeling and Education...

  • Product testing.  // Current Health 1;May92, Vol. 15 Issue 9, p22 

    Discusses the medicine and product testing conducted by the US Food and Drug Administration (FDA). Pharmaceutical tests; How the FDA studies test results; FDA approval; Drug testing in other countries; Tests on food, cosmetics, pesticides; The FDA's concern about food labels; Testing donated blood.

  • Dateline Washington.  // Consumers' Research Magazine;Feb1993, Vol. 76 Issue 2, p6 

    Reports that in January a US District Court judge ruled that the Food and Drug Administration (FDA) is not responsible for $210 million worth of losses incurred by Chilean fruit growers when in 1989, the FDA temporarily banned sales of grapes to the United States. Details of the ruling.

  • The Food and Drug... Coorsh, Richard // Consumers' Research Magazine;Jan1995, Vol. 78 Issue 1, p6 

    Reports on the genetically-engineered food products that passed voluntary Food and Drug Administration (FDA) inspection. Products; Producers.

  • FDA vs. UK approval time. Coorsh, Richard // Consumers' Research Magazine;Jan1996, Vol. 79 Issue 1, p6 

    Reports on a General Accounting Office report stating that the Food and Drug Administration (FDA) processes applications as fast or faster than its counterpart in Great Britain. Plans to reform the FDA.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics